Chibaatar, E.; Fujii, R.; Ikenouchi, A.; Okamoto, N.; Natsuyama, T.; Hayasaki, G.; Shinkai, T.; Yoshimura, R.
Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology. Int. J. Mol. Sci. 2024, 25, 13663.
https://doi.org/10.3390/ijms252413663
AMA Style
Chibaatar E, Fujii R, Ikenouchi A, Okamoto N, Natsuyama T, Hayasaki G, Shinkai T, Yoshimura R.
Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology. International Journal of Molecular Sciences. 2024; 25(24):13663.
https://doi.org/10.3390/ijms252413663
Chicago/Turabian Style
Chibaatar, Enkhmurun, Rintarou Fujii, Atsuko Ikenouchi, Naomichi Okamoto, Tomoya Natsuyama, Gaku Hayasaki, Takahiro Shinkai, and Reiji Yoshimura.
2024. "Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology" International Journal of Molecular Sciences 25, no. 24: 13663.
https://doi.org/10.3390/ijms252413663
APA Style
Chibaatar, E., Fujii, R., Ikenouchi, A., Okamoto, N., Natsuyama, T., Hayasaki, G., Shinkai, T., & Yoshimura, R.
(2024). Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology. International Journal of Molecular Sciences, 25(24), 13663.
https://doi.org/10.3390/ijms252413663
